When Diginex shareholders gather on October 8, they won’t just be voting on an acquisition. They’ll be deciding whether the company’s expansion strategy — one that has already multiplied its losses sixfold — deserves another, far larger, injection of paper equity.
The numbers laid out in the company’s fiscal 2026 results tell a story of a business growing in size while bleeding from its core operations. Revenue climbed 77 percent to $3.6 million, a headline figure that flatters more than it reveals. That jump was purchased, not earned: it reflects partial-period contributions from Matter, acquired in October 2025, alongside Plan A and The Remedy Project, both bought in January 2026. Strip out those deals and the organic picture looks considerably thinner.
The cost side of the ledger is where the strain shows. Net losses ballooned to $31.1 million, against $5.2 million the prior year and $4.9 million the year before that. Headcount tells a similar tale: the workforce expanded from 32 employees at the end of March 2025 to 114 a year later, with 79 of those 82 new positions arriving through acquisitions. Diginex is buying substance, but it is paying a heavy price to do so.
Rapid growth through acquisitions brings operational complexity — and with it, new workplace risks that need documenting. A free toolkit with 41 ready-to-use templates helps you keep your risk assessments current as your team expands. Download the free Risk Assessment Toolkit
A Deal That Rewrites the Shareholder Register
The Resulticks transaction dwarfs everything that came before it. The company plans to issue 600 million new Diginex shares at $1.75 apiece as consideration — an all-paper deal that, when measured against the current market capitalization of €33.15 million, makes the dilution the story, not the acquisition itself.
That dilution is stark. Under the proposed structure, Resulticks shareholders and the new $50 million investors would together hold roughly 86 percent of the enlarged company. Existing Diginex holders would be left with a fraction of what they currently own. The company has also secured $70 million in commitments from private investors to fund operations, integration, and further growth, with an additional $20 million capital raise announced in August comprising 20 million common shares and five-year warrants exercisable at $1.
Should investors sell immediately? Or is it worth buying Diginex?
There is, to be fair, a substantial asset on the other side of the ledger. Resulticks reported $150 million in revenue for fiscal 2025 with $17 million in after-tax profit, and has compounded at over 60 percent annually since the pandemic. The company brings a footprint spanning North America, Asia, and the Middle East, complementing Diginex’s base in London and Europe. If the integration closes as planned by October 30, Diginex would operate on an entirely different scale.
The Market’s Verdict So Far: Nervous
The share price is already reflecting the uncertainty. Diginex closed at $1.24 on Tuesday, up 2.5 percent on the day, but down 23 percent on the week. The annualized volatility of 119 percent captures just how much the market is struggling to price in the outcome. With no analyst coverage offering price targets, investors are left to make their own calculations from the company’s disclosures alone.
The transaction is not guaranteed to close. Shareholder approval is one condition; Nasdaq’s clearance for the initial listing is another. The company itself acknowledges that neither the vote nor the remaining closing conditions are assured. At such a small market capitalization, there is little margin for error — a sustained low share price could itself threaten compliance with Nasdaq’s listing requirements.
When a business is under financial scrutiny, health and safety compliance is often the last thing on leadership’s mind — yet it’s a legal duty that can’t be deferred. Over 37,000 UK companies use a free Health & Safety Toolkit to stay compliant with the Health & Safety at Work Act 1974, COSHH, and more. Get the free Health & Safety Toolkit
Two Stories, One Ballot
The October vote ultimately pits two narratives against each other. One is a loss-making operating business that has grown through serial acquisitions funded almost entirely by equity issuance rather than debt — the company finished the year debt-free, but that cleanliness is achieved by pushing the cost onto shareholders with every new issue. The other is a bet that Resulticks’ growth trajectory will eventually justify the massive dilution required to bring it in.
Diginex has a history here. The company has repeatedly turned to capital raises, earn-outs, and employee programs to fund its ambitions, a pattern that has not gone unnoticed in the investor community. Whether the Resulticks deal is the culmination of that strategy or its breaking point is the question shareholders will answer on October 8 — and the answer will only truly arrive afterward, when the market sees whether Resulticks’ growth rates were worth the price paid in equity.
Ad
Diginex Stock: Buy or Sell?! New Diginex Analysis from August 19 delivers the answer:
The latest Diginex figures speak for themselves: Urgent action needed for Diginex investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 19.
Diginex: Buy or sell? Read more here...
